Peter Melby, M.D.
Professor, Division of Infectious Diseases
Peter Melby, M.D.
Director, UTMB Center for Tropical Diseases
Department of Internal Medicine
Division of Infectious Diseases
University of Texas Medical Branch
301 University Blvd, Marvin Graves Bldg., Rm 4.210
Galveston, Texas 77555-0435
|Degree/Training Completed||Year||Name & Location|
|M.D.||1983||University of Colorado, Denver, Colorado|
|Internal Medicine||1986||University of Missouri, Columbia, Missouri|
|Infectious Diseases||1990||Laboratory of Parasitic Diseases, NIH, Bethesda, MD Univ. of Texas Health Science Center, San Antonio|
Dr. Melby joined UTMB in 2010 as Professor of Internal Medicine in the Division of Infectious Diseases and Director of the UTMB Center for Tropical Diseases. He has an active research program related to the immunopathogenesis of parasitic diseases, with a particular focus on leishmaniasis. His laboratory has been involved in vaccine development, studies to determine immunopathological mechanisms of disease, studies to define the impact of malnutrition on innate immunity and visceral leishmaniasis, and drug discovery. Dr. Melby's interest in tropical diseases and the neglected diseases of resource-poor developing countries started thirty years ago when he first worked overseas in a hospital laboratory in rural Egypt. He subsequently returned to the U.S. to attend medical school at the University of Colorado and then went on to complete his residency in Internal Medicine at the University of Missouri, a research fellowship in the Laboratory of Parasitic Diseases at the National Institutes of Health, and a clinical infectious diseases fellowship at the University of Texas Health Science Center, San Antonio. He is active in the clinical practice of infectious diseases and in the teaching of medical and graduate students, as well as clinical residents and fellows.
- Immunopathogenesis of leishmaniasis.
- Vaccine development for leishmaniasis
- Impact of malnutrition on innate immunity and susceptibility to infection
- Drug discovery for leishmaniasis
- International research ethics